200 related articles for article (PubMed ID: 28888210)
1. Antibody-cytokine fusion proteins for improving efficacy and safety of cancer therapy.
Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Majidi J
Biomed Pharmacother; 2017 Nov; 95():731-742. PubMed ID: 28888210
[TBL] [Abstract][Full Text] [Related]
2. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
3. Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.
Young PA; Morrison SL; Timmerman JM
Semin Oncol; 2014 Oct; 41(5):623-36. PubMed ID: 25440607
[TBL] [Abstract][Full Text] [Related]
4. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
Xiang J
Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
[TBL] [Abstract][Full Text] [Related]
5. Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy.
Hutmacher C; Neri D
Adv Drug Deliv Rev; 2019 Feb; 141():67-91. PubMed ID: 30201522
[TBL] [Abstract][Full Text] [Related]
6. Antibody-cytokine fusion proteins.
Kontermann RE
Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
[TBL] [Abstract][Full Text] [Related]
7. Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments.
Müller D
BioDrugs; 2014 Apr; 28(2):123-31. PubMed ID: 24018469
[TBL] [Abstract][Full Text] [Related]
8. Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.
Murer P; Neri D
N Biotechnol; 2019 Sep; 52():42-53. PubMed ID: 30991144
[TBL] [Abstract][Full Text] [Related]
9. Antibody-cytokine fusion proteins: applications in cancer therapy.
Ortiz-Sánchez E; Helguera G; Daniels TR; Penichet ML
Expert Opin Biol Ther; 2008 May; 8(5):609-32. PubMed ID: 18407765
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
11. Antibody-cytokine fusion proteins for the therapy of cancer.
Penichet ML; Morrison SL
J Immunol Methods; 2001 Feb; 248(1-2):91-101. PubMed ID: 11223071
[TBL] [Abstract][Full Text] [Related]
12. Antibody fusions with immunomodulatory proteins for cancer therapy.
Müller D
Pharmacol Ther; 2015 Oct; 154():57-66. PubMed ID: 26145167
[TBL] [Abstract][Full Text] [Related]
13. Genetically engineered fusion proteins for treatment of cancer.
Weidle UH; Schneider B; Georges G; Brinkmann U
Cancer Genomics Proteomics; 2012 Nov; 9(6):357-72. PubMed ID: 23162075
[TBL] [Abstract][Full Text] [Related]
14. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
Gillies SD; Lan Y; Brunkhorst B; Wong WK; Li Y; Lo KM
Cancer Immunol Immunother; 2002 Oct; 51(8):449-60. PubMed ID: 12202906
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy.
Christ O; Seiter S; Matzku S; Burger C; Zöller M
Clin Cancer Res; 2001 Apr; 7(4):985-98. PubMed ID: 11309350
[TBL] [Abstract][Full Text] [Related]
16. Antibody-cytokine fusion proteins for the therapy of cancer.
Helguera G; Penichet ML
Methods Mol Med; 2005; 109():347-74. PubMed ID: 15585931
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity.
Neri D
Cancer Immunol Res; 2019 Mar; 7(3):348-354. PubMed ID: 30824549
[TBL] [Abstract][Full Text] [Related]
18. Cytokine engineering for targeted cancer immunotherapy.
Bonati L; Tang L
Curr Opin Chem Biol; 2021 Jun; 62():43-52. PubMed ID: 33684633
[TBL] [Abstract][Full Text] [Related]
19. Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy.
Ren Z; Zhang X; Fu YX
Clin Cancer Res; 2024 May; 30(10):2025-2038. PubMed ID: 38190116
[TBL] [Abstract][Full Text] [Related]
20. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer.
Dela Cruz JS; Huang TH; Penichet ML; Morrison SL
Clin Exp Med; 2004 Oct; 4(2):57-64. PubMed ID: 15672942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
